New aspects in diabetes: treatment strategies with alpha-glucosidase inhibitors
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Berlin u.a.
<<de>> Gruyter
1992
|
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XII, 294 S. graph. Darst |
| ISBN: | 3110134691 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV005405017 | ||
| 003 | DE-604 | ||
| 005 | 19991108 | ||
| 007 | t | ||
| 008 | 920427s1992 gw d||| |||| 10||| eng d | ||
| 020 | |a 3110134691 |9 3-11-013469-1 | ||
| 035 | |a (OCoLC)28749394 | ||
| 035 | |a (DE-599)BVBBV005405017 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 |a DE-188 | ||
| 050 | 0 | |a RC660.A15 | |
| 084 | |a YC 6805 |0 (DE-625)153250:12911 |2 rvk | ||
| 245 | 1 | 0 | |a New aspects in diabetes |b treatment strategies with alpha-glucosidase inhibitors |c Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ... |
| 264 | 1 | |a Berlin u.a. |b <<de>> Gruyter |c 1992 | |
| 300 | |a XII, 294 S. |b graph. Darst | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 2 | |a Diabète - Traitement médicamenteux - Congrès comme sujet | |
| 650 | 2 | |a Triholosides - usage thérapeutique - Congrès comme sujet | |
| 650 | 2 | |a alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet | |
| 650 | 4 | |a Diabetes Mellitus |x drug therapy |v Congresses | |
| 650 | 4 | |a Diabetes |x Treatment |v Congresses | |
| 650 | 4 | |a Glucosidases |x Inhibitors |v Congresses | |
| 650 | 4 | |a Trisaccharides |x therapeutic use |v Congresses | |
| 650 | 4 | |a alpha-Glucosidases |x antagonists & inhibitors |v Congresses | |
| 650 | 0 | 7 | |a Diabetes mellitus Typ 2 |0 (DE-588)1194598587 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Acarbose |0 (DE-588)4141222-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Glucosidase |g alpha- |0 (DE-588)4201497-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Enzyminhibitor |0 (DE-588)4152479-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z München |2 gnd-content | |
| 689 | 0 | 0 | |a Diabetes mellitus Typ 2 |0 (DE-588)1194598587 |D s |
| 689 | 0 | 1 | |a Acarbose |0 (DE-588)4141222-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Diabetes mellitus Typ 2 |0 (DE-588)1194598587 |D s |
| 689 | 1 | 1 | |a Glucosidase |g alpha- |0 (DE-588)4201497-9 |D s |
| 689 | 1 | 2 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Lefebvre, Pierre J. |e Sonstige |4 oth | |
| 711 | 2 | |a International Symposium on Acarbose |n 3 |d 1991 |c München |j Sonstige |0 (DE-588)2122461-4 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003382961 | ||
Datensatz im Suchindex
| _version_ | 1804119616973176832 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV005405017 |
| callnumber-first | R - Medicine |
| callnumber-label | RC660 |
| callnumber-raw | RC660.A15 |
| callnumber-search | RC660.A15 |
| callnumber-sort | RC 3660 A15 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 6805 |
| ctrlnum | (OCoLC)28749394 (DE-599)BVBBV005405017 |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02267nam a2200553 c 4500</leader><controlfield tag="001">BV005405017</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19991108 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920427s1992 gw d||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3110134691</subfield><subfield code="9">3-11-013469-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28749394</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005405017</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC660.A15</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 6805</subfield><subfield code="0">(DE-625)153250:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New aspects in diabetes</subfield><subfield code="b">treatment strategies with alpha-glucosidase inhibitors</subfield><subfield code="c">Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin u.a.</subfield><subfield code="b"><<de>> Gruyter</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 294 S.</subfield><subfield code="b">graph. Darst</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Diabète - Traitement médicamenteux - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Triholosides - usage thérapeutique - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes Mellitus</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucosidases</subfield><subfield code="x">Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trisaccharides</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">alpha-Glucosidases</subfield><subfield code="x">antagonists & inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diabetes mellitus Typ 2</subfield><subfield code="0">(DE-588)1194598587</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Acarbose</subfield><subfield code="0">(DE-588)4141222-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glucosidase</subfield><subfield code="g">alpha-</subfield><subfield code="0">(DE-588)4201497-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">München</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Diabetes mellitus Typ 2</subfield><subfield code="0">(DE-588)1194598587</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Acarbose</subfield><subfield code="0">(DE-588)4141222-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Diabetes mellitus Typ 2</subfield><subfield code="0">(DE-588)1194598587</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Glucosidase</subfield><subfield code="g">alpha-</subfield><subfield code="0">(DE-588)4201497-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lefebvre, Pierre J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Symposium on Acarbose</subfield><subfield code="n">3</subfield><subfield code="d">1991</subfield><subfield code="c">München</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2122461-4</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003382961</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 München gnd-content |
| genre_facet | Konferenzschrift 1991 München |
| id | DE-604.BV005405017 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:29:02Z |
| institution | BVB |
| institution_GND | (DE-588)2122461-4 |
| isbn | 3110134691 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003382961 |
| oclc_num | 28749394 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-188 |
| physical | XII, 294 S. graph. Darst |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | <<de>> Gruyter |
| record_format | marc |
| spelling | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ... Berlin u.a. <<de>> Gruyter 1992 XII, 294 S. graph. Darst txt rdacontent n rdamedia nc rdacarrier Literaturangaben Diabète - Traitement médicamenteux - Congrès comme sujet Triholosides - usage thérapeutique - Congrès comme sujet alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet Diabetes Mellitus drug therapy Congresses Diabetes Treatment Congresses Glucosidases Inhibitors Congresses Trisaccharides therapeutic use Congresses alpha-Glucosidases antagonists & inhibitors Congresses Diabetes mellitus Typ 2 (DE-588)1194598587 gnd rswk-swf Acarbose (DE-588)4141222-9 gnd rswk-swf Glucosidase alpha- (DE-588)4201497-9 gnd rswk-swf Enzyminhibitor (DE-588)4152479-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 München gnd-content Diabetes mellitus Typ 2 (DE-588)1194598587 s Acarbose (DE-588)4141222-9 s DE-604 Glucosidase alpha- (DE-588)4201497-9 s Enzyminhibitor (DE-588)4152479-2 s Lefebvre, Pierre J. Sonstige oth International Symposium on Acarbose 3 1991 München Sonstige (DE-588)2122461-4 oth |
| spellingShingle | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors Diabète - Traitement médicamenteux - Congrès comme sujet Triholosides - usage thérapeutique - Congrès comme sujet alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet Diabetes Mellitus drug therapy Congresses Diabetes Treatment Congresses Glucosidases Inhibitors Congresses Trisaccharides therapeutic use Congresses alpha-Glucosidases antagonists & inhibitors Congresses Diabetes mellitus Typ 2 (DE-588)1194598587 gnd Acarbose (DE-588)4141222-9 gnd Glucosidase alpha- (DE-588)4201497-9 gnd Enzyminhibitor (DE-588)4152479-2 gnd |
| subject_GND | (DE-588)1194598587 (DE-588)4141222-9 (DE-588)4201497-9 (DE-588)4152479-2 (DE-588)1071861417 |
| title | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors |
| title_auth | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors |
| title_exact_search | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors |
| title_full | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ... |
| title_fullStr | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ... |
| title_full_unstemmed | New aspects in diabetes treatment strategies with alpha-glucosidase inhibitors Third International Symposium on Acarbose. Ed. P. J. Lefèbvre ... |
| title_short | New aspects in diabetes |
| title_sort | new aspects in diabetes treatment strategies with alpha glucosidase inhibitors |
| title_sub | treatment strategies with alpha-glucosidase inhibitors |
| topic | Diabète - Traitement médicamenteux - Congrès comme sujet Triholosides - usage thérapeutique - Congrès comme sujet alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet Diabetes Mellitus drug therapy Congresses Diabetes Treatment Congresses Glucosidases Inhibitors Congresses Trisaccharides therapeutic use Congresses alpha-Glucosidases antagonists & inhibitors Congresses Diabetes mellitus Typ 2 (DE-588)1194598587 gnd Acarbose (DE-588)4141222-9 gnd Glucosidase alpha- (DE-588)4201497-9 gnd Enzyminhibitor (DE-588)4152479-2 gnd |
| topic_facet | Diabète - Traitement médicamenteux - Congrès comme sujet Triholosides - usage thérapeutique - Congrès comme sujet alpha-Glucosidase - antagonistes et inhibiteurs - Congrès comme sujet Diabetes Mellitus drug therapy Congresses Diabetes Treatment Congresses Glucosidases Inhibitors Congresses Trisaccharides therapeutic use Congresses alpha-Glucosidases antagonists & inhibitors Congresses Diabetes mellitus Typ 2 Acarbose Glucosidase alpha- Enzyminhibitor Konferenzschrift 1991 München |
| work_keys_str_mv | AT lefebvrepierrej newaspectsindiabetestreatmentstrategieswithalphaglucosidaseinhibitors AT internationalsymposiumonacarbosemunchen newaspectsindiabetestreatmentstrategieswithalphaglucosidaseinhibitors |